You've been on birth control for years. Maybe it helped at first, or maybe it never did. But here you are, still in pain, still missing work, still wondering why nobody explains what's actually happening. You're not failing. And this isn't a compliance problem. The premise is wrong — the idea that suppressing your period will fix endometriosis. It won't. And that's because endometriosis isn't just about menstrual bleeding.
Endometriosis affects 1 in 10 women of reproductive age. It's a chronic condition driven by escaped endometrial tissue that sets off inflammation, neural infiltration (nerves growing into lesions), and central sensitization (a state where your nervous system gets stuck amplifying pain signals, even long after the initial injury). Pain in endometriosis comes from multiple overlapping mechanisms at the same time. No single medication targets all of them. That's why birth control alone leaves approximately one-third of patients in significant pain, and why rates are even worse for those with deep disease or a sensitized nervous system.
What does birth control actually do for endometriosis pain?
Combined oral contraceptives work by shutting down ovulation and reducing the amount of estrogen stimulating endometrial growth. That reduces menstrual bleeding. It can reduce period pain. But it does not eliminate the endometrial implants already growing outside your uterus. It does not reverse nerve infiltration into lesions. It does not reset your nervous system.
More importantly, your endometriotic tissue shows progesterone resistance. That means the tissue doesn't respond appropriately to the hormonal "off" signal birth control is trying to send. You can take it perfectly and still be in pain because the mechanism that should work doesn't work in endometriosis tissue.
Stop telling yourself you're doing something wrong. You're taking the medication as prescribed. The biology of your disease is simply more complicated than a single medication can address.
Why does endometriosis pain persist on birth control?
Endometriosis pain comes from at least three sources at once:
- Prostaglandin-driven inflammation from the lesions themselves
- Nerves that have infiltrated the lesions and the surrounding tissue, firing constantly
- Central sensitization in your nervous system, where pain signals get amplified in the spinal cord and brain
- Pelvic floor dysfunction that tightens and perpetuates pain independent of disease activity
Birth control addresses only the first source by reducing menstrual bleeding. It leaves the other three untouched. That's why you might get some relief, but not complete relief. And that's why a comprehensive approach requires targeting multiple mechanisms simultaneously — a comprehensive treatment plan typically addresses what hormonal suppression alone cannot reach.
Does the gut microbiome (estrobolome) make birth control less effective?
Here's something most patients never hear about. Your liver processes estrogen and tags it for elimination through your bowel. But if your gut microbiome is dysbiotic, which research shows it is in many women with endometriosis, bacteria produce an enzyme called beta-glucuronidase that cuts that tag off. The estrogen gets reabsorbed back into your bloodstream instead of leaving your body.
This recycling system is called the estrobolome: the collection of gut bacteria responsible for metabolizing estrogen. In women with endometriosis, the estrobolome appears consistently dysregulated, producing more beta-glucuronidase and recycling more estrogen. The result is a higher estrogen load in your body than your hormonal treatment is designed to suppress.
This doesn't mean birth control isn't working as designed. It means birth control is trying to reduce estrogen while another system in your body is actively recycling it back up. Your treatment is fighting a two-front battle. Research increasingly supports addressing gut health alongside hormonal therapy — not as an alternative to it, but as a complementary approach. The estrobolome connection is an active area of investigation, and the clinical implications are still being defined.
Do NSAIDs help endometriosis pain?
NSAIDs (ibuprofen, naproxen) and COX-2 selective inhibitors (celecoxib) work by blocking the enzymes that produce prostaglandins, the inflammatory molecules that drive period pain and bowel symptoms in endometriosis. A 2017 Cochrane review confirmed NSAIDs are more effective than placebo for this type of pain.
For NSAIDs to work, you need continuous dosing starting 1-2 days before your period and continuing through the heavy flow days. Not taking it when the pain starts. That's a different strategy.
The catch: NSAIDs don't stop lesions from growing, and long-term use carries cardiovascular and renal risks. They're an adjunct, not a replacement for disease-modifying therapy.
Is dienogest better than birth control for endometriosis?
For many patients with persistent pain on combined oral contraceptives, yes. Multiple head-to-head randomized trials and a growing body of meta-analytic evidence have now compared dienogest 2 mg daily directly to combined oral contraceptives. Dienogest is non-inferior to combined oral contraceptives for reducing pelvic pain, dysmenorrhea, and dyspareunia, produces measurably better quality of life scores in some studies, and avoids the estrogen-related clot risk that combined pills carry — relevant if you have migraine with aura, smoke, or have other clot risk factors.
Dienogest works through a mechanism birth control doesn't: it directly suppresses the local aromatase activity that endometriotic lesions use to make their own estrogen, hitting the disease tissue where it lives rather than only suppressing ovarian output. The trade-off is breakthrough bleeding, which is more common in the first three to six months of dienogest use and usually settles with time. If birth control hasn't controlled your pain, asking your provider specifically about switching to dienogest 2 mg daily is a reasonable next step to discuss before moving to GnRH drugs or surgery.
If birth control isn't working, stronger progestin-only regimens often are. Unlike the low-dose progestin in many birth control pills, these are designed to suppress lesional growth more aggressively.
Dienogest 2 mg daily has the strongest evidence base of any oral progestin for endometriosis specifically. Randomized trials have found it significantly reduces endometriosis pain compared to placebo and is comparable to GnRH agonists (which induce temporary medical menopause) without the degree of bone loss associated with GnRH agonist therapy. Dienogest works differently than other progestins: it suppresses local aromatase activity (enzymes that produce estrogen directly in the lesions), so it hits the tissue where it lives, not just systemically.
Norethindrone acetate 5 mg daily is a well-established, lower-cost option with comparable efficacy in real-world practice.
Levonorgestrel-releasing IUD (Mirena) delivers progestin directly to the uterus with minimal systemic absorption. A meta-analysis of randomized controlled trials found it significantly reduced dysmenorrhea and pelvic pain after endometriosis surgery when used as postoperative maintenance therapy. For women with heavy bleeding or who tolerate pills poorly, this is often a better choice than systemic pills.
What about Lupron and other GnRH agonists for endometriosis?
GnRH agonists (Lupron/leuprolide, nafarelin, goserelin) induce a temporary medical menopause by shutting down the pituitary signal to your ovaries, which crashes estrogen production. They reduce endometriosis pain about as effectively as birth control or progestins, but the side effects — bone loss, hot flashes, mood changes — are why they're typically used for short courses or with hormonal "add-back" therapy rather than as a first-line option.
GnRH agonists (leuprolide, nafarelin, goserelin) work by shutting down the pituitary, which shuts down your ovaries, which eliminates most of the estrogen in your body. For pain, they're as effective as birth control or progestins. The problem: they cause bone loss, hot flashes, and mood changes. You can only use them for 6 months without damage to your skeleton unless you add back low-dose hormones (estrogen plus progestin to prevent the side effects while keeping the benefit).
What are GnRH antagonists (Orilissa/elagolix) for endometriosis?
GnRH antagonists are oral medications that suppress estrogen quickly without the initial symptom flare that GnRH agonists cause. Elagolix (Orilissa) was the first oral GnRH antagonist FDA-approved for endometriosis pain. In the ELARIS I and II trials (n=872), the high-dose version (200 mg twice daily) reduced dysmenorrhea response in 75.8% of patients versus 19.6% on placebo, and reduced non-menstrual pelvic pain in 54.5% versus 36.5% on placebo. Like agonists, antagonists cause bone density loss, so they're typically used with add-back hormonal therapy when courses extend beyond a few months.
GnRH antagonists are newer and work faster without the initial flare of symptoms agonists cause. Elagolix (Orilissa) is an oral GnRH antagonist that was studied in two large clinical trials (ELARIS I and II, n=872 patients). Both low-dose and high-dose versions reduced period pain and non-menstrual pelvic pain versus placebo. The high-dose version (200 mg twice daily) achieved the best results. Like agonists, you need add-back hormones after a few months to protect your bones.
GnRH drugs are typically reserved for when other options haven't worked, mainly because of the side effects and cost (Orilissa runs roughly $845 a month (as of 2026; pricing varies by insurance and may change)). If your pain is severe and refractory and you've optimized progestins and pelvic floor PT, they're worth discussing with your provider.
Are aromatase inhibitors the next step if hormones fail?
Here's something most patients don't know: your endometrial lesions make their own estrogen. They express aromatase, the enzyme that produces estrogen locally, independent of your ovaries. Birth control and progestins suppress ovarian estrogen, but they don't stop the lesions from making their own. This is why some women with refractory pain need an additional layer.
Aromatase inhibitors (letrozole, anastrozole) block this local estrogen production. They're typically combined with a progestin or birth control to prevent your ovaries from overcompensating and growing cysts. Evidence from randomized trials shows aromatase inhibitors significantly reduce pain in women whose pain persists on standard hormonal therapy.
The trade-off: bone loss. If you use an aromatase inhibitor, you typically add back a bisphosphonate (a bone-protective medication) or progestin to minimize this. This is a second- or third-line strategy, not first-line, but it works.
Do omega-3, magnesium, or diet help endometriosis?
Omega-3 supplementation (EPA and DHA) works by outcompeting arachidonic acid in your cells, reducing substrate for prostaglandin production. Large prospective studies have found higher dietary omega-3 intake is associated with a meaningfully lower risk of incident endometriosis. Effect size is modest but clinically real. Typical dose: 1,080 mg EPA plus 720 mg DHA daily.
Magnesium glycinate helps by relaxing smooth muscle in the uterus and blocking calcium channels in muscle cells. A Cochrane review found moderate-quality evidence that magnesium is better than placebo for dysmenorrhea. Typical dose: 250-360 mg elemental magnesium daily.
These are not replacements for medication, but they address inflammation from a different angle and can meaningfully reduce pain when combined with medical therapy.
Does pelvic floor physical therapy help endometriosis?
Endometriosis causes your pelvic floor muscles to tighten up. That tightness perpetuates pain independently of whether your lesions are still active. Pelvic floor physical therapy — myofascial release, trigger point work, and neuromuscular re-education — addresses this muscular pain driver directly. Medications don't.
Specialized pelvic floor PT has been shown in clinical studies to significantly reduce dyspareunia (painful intercourse), period pain, and chronic pelvic pain in women with endometriosis. More importantly, it works through a different mechanism than hormones: manual therapy modulates pain signal amplification in the spinal cord and brain through descending inhibitory pathways. Translation: it targets a different part of the pain system.
The 2022 ESHRE guideline recommends pelvic floor PT as standard care alongside medical or surgical management. If you're on medication and still in pain, pelvic floor PT is not optional. It's essential.
Does TENS or neuromodulation help endometriosis pain?
Transcutaneous electrical nerve stimulation (TENS) applies gentle electric current to your skin to modulate pain signals in the spinal cord. Clinical evidence, including a Cochrane review of TENS for dysmenorrhea, supports its use as a low-risk adjunct for menstrual pain. It's not a replacement for other therapies, but some patients find it helpful alongside medical management.
Cognitive behavioral therapy and mindfulness-based stress reduction also matter. Central sensitization in endometriosis involves specific alterations in brain regions that regulate pain, and these changes respond to top-down regulatory strategies. Research into psychological interventions for endometriosis-related pain shows significant reductions in pain catastrophizing and pain-related quality of life impairment.
When is excision surgery the right choice for endometriosis?
Laparoscopic excision by a surgeon experienced in endometriosis removes lesions and can provide durable pain relief. A 2014 Cochrane review found moderate-quality evidence that laparoscopic surgery reduces overall pain compared to diagnostic laparoscopy alone. A 2020 update of this review noted that the evidence on pain outcomes remains uncertain due to study limitations, while moderate-quality evidence supports improved pregnancy rates. Surgery works for removing visible current disease.
The reality: recurrence is substantial. Research estimates a cumulative 5-year recurrence rate for endometriosis pain in the range of 40–50% following conservative surgery. This means surgery removes current lesions but doesn't change the underlying biology that allowed them to grow in the first place. That's why most patients benefit from postoperative medical suppression to extend symptom-free intervals.
Surgery is not a cure. It's a reset button. It needs to be followed by comprehensive medical management to prevent disease from regrowing.
What's the multimodal endometriosis treatment plan?
Here's what research actually supports: simultaneous targeting of multiple mechanisms. Not sequential. Not waiting to "try birth control first." Simultaneous.
If your pain persists on birth control, your plan might include:
- A stronger progestin or GnRH drug to suppress lesional growth more aggressively
- NSAIDs dosed continuously, not as rescue medication
- Pelvic floor physical therapy to address muscular pain
- Omega-3 and magnesium to reduce inflammatory substrate
- Possibly surgical excision if you have large cysts, bowel disease, or anatomy affecting fertility
The architecture of your plan should match what's actually driving your pain, not a standard protocol everyone gets.
How does endometriosis treatment affect intimacy and sex?
Endometriosis affects sexual function in the majority of women who have it. Pain with sex (dyspareunia) is the most obvious mechanism, but there's more: reduced libido from chronic pain, side effects from medications, and the psychological toll of living with a disease that makes sex difficult. Systematic reviews of sexual function in endometriosis have found that sexual dysfunction extends beyond painful intercourse to include decreased satisfaction, reduced desire, and difficulty with arousal.
This isn't something to live with quietly. It's a quality of life outcome that deserves to be part of the treatment conversation.
Pelvic floor physical therapy specifically reduces painful intercourse. Specialized pelvic floor PT has been shown to significantly reduce dyspareunia in women with endometriosis. This is the same PT recommended for period pain and chronic pelvic pain, but the dyspareunia reduction is particularly important for sexual health outcomes.
Cognitive-behavioral therapy improves sexual satisfaction in endo patients. A randomized clinical trial of CBT in women with endometriosis found significant improvements in sexual satisfaction scores immediately after the intervention and sustained at one month follow-up. The mechanism is partly physical (reducing pain-driven avoidance) and partly psychological (changing negative thoughts about sex that are reinforced by repeated pain). CBT works through a different pathway than medication, making it a meaningful addition to comprehensive treatment.
Intimacy recovery is not a luxury add-on. It's an essential part of treating endometriosis and deserves to be discussed with your care team, alongside medications and pelvic floor work.
What to say to your doctor about endometriosis treatment
If you're on birth control and still in pain, bring this conversation to your next appointment:
"Birth control isn't controlling my pain. I understand it suppresses menstruation, but endometriosis pain comes from multiple mechanisms — inflammation, nerve infiltration, and nervous system sensitization — and suppressing my period alone isn't addressing all of them. I'd like to discuss stronger options."
Then ask specifically:
- Dienogest 2 mg daily: "Can we try a progestin-only regimen? Dienogest has the strongest evidence for endometriosis specifically and works through a mechanism birth control doesn't."
- Continuous NSAIDs: "I want to try continuous NSAIDs starting 1-2 days before my period and continuing through the heavy days, not just when pain breaks through. Has my GI history been reviewed for safety?"
- Pelvic floor physical therapy: "I have pelvic floor dysfunction that contributes to my pain. Can you refer me to a specialized pelvic floor PT? This targets pain my medications don't."
- If those don't work: "If first-line medical management doesn't provide adequate relief, what's the next step? GnRH agonists with add-back therapy? Aromatase inhibitors? Surgical evaluation?"
What to keep in mind: A comprehensive treatment plan typically addresses what hormonal suppression alone cannot reach — central sensitization, pelvic floor dysfunction, and gut health. If birth control alone hasn't provided adequate relief, you are entitled to explore additional options with your provider or seek a specialist referral. You deserve a provider who acknowledges that and moves forward with real alternatives.
What you need to know for the conversation: You are not doing something wrong. Your disease is simply more complex than a single mechanism medication can address. Medicine knows this. A good provider will have this conversation with you.
What the guidelines say: In 2022, ESHRE (the European Society of Human Reproduction and Embryology) formally moved away from requiring laparoscopy for diagnosis and recognized that symptoms plus imaging are sufficient to initiate treatment. In 2026, ACOG issued its first dedicated endometriosis diagnostic guideline (Clinical Practice Guideline No. 11), explicitly stating that a clinical diagnosis based on history, symptoms, and physical exam is sufficient to begin empiric medical therapy. Diagnostic laparoscopy is no longer required before starting treatment. Europe codified this in 2022. The United States officially caught up in 2026. If your provider is still requiring surgery before beginning medical treatment, it is worth asking whether their approach reflects current clinical guidance from both ESHRE and ACOG.
Frequently Asked Questions
I've been on birth control for 2 years and still in pain. Does that mean I need surgery?
No. It means birth control alone isn't addressing all your pain mechanisms. Before jumping to surgery, try a stronger progestin like dienogest, add continuous NSAIDs, and get a referral to pelvic floor PT. Many women find meaningful relief with these adjustments. Surgery is the right move if you have large cysts, bowel involvement, or anatomy affecting fertility. Otherwise, optimize medical management first. An experienced endometriosis provider can help you figure out which path applies to you.
Can I use multiple treatments at the same time?
Yes, and that's often the best approach. Medications target disease and inflammation. Pelvic floor PT targets muscular dysfunction and nervous system sensitization. Omega-3 and magnesium reduce inflammatory substrate. NSAIDs block prostaglandins. These hit different targets simultaneously, which is closer to how endometriosis actually works (multiple mechanisms driving pain at once).
How long until I know if something is working?
NSAIDs and progestins typically show effect within 1-3 menstrual cycles. Pelvic floor PT requires 8-12 weeks of consistent treatment. Supplements take 2-3 months. Don't evaluate anything before 3 months of consistent use. One or two bad cycles doesn't mean it's not working.
My doctor says birth control is the only option. What should I do?
If birth control alone has not provided adequate relief, you are entitled to explore additional options with your provider or seek a specialist referral. A knowledgeable endometriosis provider will discuss what hormonal suppression alone cannot address — central sensitization, pelvic floor dysfunction, and gut health — and will work with you on a comprehensive plan. Not all gynecologists have deep expertise in refractory endometriosis. Finding one who does is a reasonable step.
Is there a "best" treatment?
No. The best treatment is the one that addresses your specific pain mechanisms. Some women need dienogest. Others need a GnRH antagonist. Others primarily need pelvic floor PT because their pain is muscular. Still others need surgery because they have anatomical disease that won't respond to medication alone. This is why the "what to say to your doctor" section is about asking the right questions, not picking the right medication.
References
- Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256. doi:10.1056/NEJMra1810764
- Morotti M, Vincent K, Becker CM. Mechanism of pain in endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017;209:8–13. doi:10.1016/j.ejogrb.2016.07.497
- Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update. 2011;17(3):327–346. doi:10.1093/humupd/dmq050
- Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2017;(11):CD004753. doi:10.1002/14651858.CD004753.pub3
- Nasu K, Nishida M, Narahara H. Aberrant expression of prostaglandin receptor and prostaglandin E2 production by endometriosis. Curr Drug Targets. 2012;13(9):1180–1186.
- Cobellis L, Razzi S, De Simone S, et al. The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. Eur J Obstet Gynecol Reprod Biol. 2004;116(1):100–102.
- Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod. 2010;25(3):633–641. doi:10.1093/humrep/dep469
- Strowitzki T, Faustmann T, Gerlinger C, Seitz C. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2010;151(2):193–198. doi:10.1016/j.ejogrb.2010.04.002
- Youn SS, Park M, Lee GW, Lee KH, Chang HK, Kwak SM, Yoo HJ. Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2019;234:32–38. doi:10.1016/j.ejogrb.2018.11.022
- Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2010;(12):CD008475. doi:10.1002/14651858.CD008475.pub2
- Bedaiwy MA, Allaire C, Yong P, Casper R. Medical management of endometriosis in patients with chronic pelvic pain. Semin Reprod Med. 2017;35(1):38–53.
- Taylor HS, Giudice LC, Lessey BA, et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377(1):28–40. doi:10.1056/NEJMoa1700089
- Surrey E, Taylor HS, Giudice L, et al. Long-term outcomes of elagolix in women with endometriosis. Obstet Gynecol. 2018;132(1):147–160. doi:10.1097/AOG.0000000000002675
- As-Sanie S, Kim J, Schmidt-Wilcke T, et al. Functional connectivity is associated with altered brain morphology in women with endometriosis-associated chronic pelvic pain. Hum Reprod. 2016;31(11):2592–2601.
- Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. doi:10.1093/hropen/hoac009
- Proctor ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2001;(3):CD002124.
- Proctor M, Farquhar C, Sinclair O, et al. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea. Cochrane Database Syst Rev. 2002;(1):CD002123. doi:10.1002/14651858.CD002123
- Duffy JM, Arambage K, Correa FJ, et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2020;(10):CD011031. doi:10.1002/14651858.CD011031.pub3
- Shakiba K, Bena JF, McGill KM, Minger J, Falcone T. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol. 2008;111(6):1285–1292. doi:10.1097/AOG.0b013e3181758ec6
- Guo S-W. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15(4):441–461. doi:10.1093/humupd/dmp007
- Saponara S, Scicchitano F, D'Alterio MN, et al. Could the estrobolome have a role in endometriosis pathogenesis and infertility? A systematic review. BMC Womens Health. 2025;26(1):43. doi:10.1186/s12905-025-04195-z
- Zhang W, Wang Y, Li N, et al. Gut dysbiosis-derived β-glucuronidase promotes the development of endometriosis. Cell Mol Life Sci. 2024;81(1):28. doi:10.1007/s00018-024-05178-3
- Moreira MF, Gamboa OL, Oliveira MAP. Cognitive-affective changes mediate the mindfulness-based intervention effect on endometriosis-related pain and mental health: a path analysis approach. Eur J Pain. 2023;27(10):1187–1202. doi:10.1002/ejp.2149
- Nikseresht M, Hafizi L, Erfanian Arghavanian F, et al. The effect of cognitive-behavioral therapy on sexual satisfaction of women with endometriosis: a randomized clinical trial. J Midwifery Reprod Health. 2025;13(3):4897–4909. doi:10.22038/JMRH.2023.72973.2134
- ACOG Clinical Practice Guideline No. 11. Diagnosis of Endometriosis. Obstet Gynecol. 2026;147(3):432–448. doi:10.1097/AOG.0000000000006181
